|
|
SCDMDG presents:
The Chemistry Of Wine
Tuesday October 28, 2014
J. Ernest Simpson, Ph.D.
Professor Emeritus
Chemistry Department
California State Polytechnic University
Pomona, CA
About Dr. Simpson
Dr. Simpson joined the Chemistry Department at California State Polytechnic University, Pomona, in 1968 after completing his B.S., M.S., and Ph.D. (organic chemistry) at the University of New Mexico and spending one year as a visiting chemistry professor at Pomona College. In 1973-74 he was on leave as visiting research associate in the Department of Enology and Viticulture at UC/Davis.
He is an active member of the American Society for Enology and Viticulture and has served on the editorial review board for the Society's journal. He has published a California wine guide. He is a member of the Society of Wine Educators and the American Wine Society. At Cal Poly he developed industrial chemistry and cooperative education courses/programs. He was the Director of Cooperative Education for Cal Poly (1980 - 2001).
His research interests are in the areas of polycyclic aromatic hydrocarbons, carbon-13-labeled compounds, and phenolic compounds, especially in grapes and wine. At Cal Poly he has been selected for exceptional merit service awards including the 2013 Provost's Award. In 1996 he was selected as the outstanding advisor in the College of Science, and his co-op program was chosen as the best in California. He is a member of ACS (San Gorgonio past chair and current councilor), California Association of Chemistry Teachers (program chairman and southern section president, 1985 - 87), and California Cooperative Education Association (president 1996-97). He was selected as an ACS Fellow in 2012, and serves on the ACS National Local Section Activities Committee.
About The Meeting
The talk will include an overview of wine and wine making and more detailed descriptions of the chemical composition of grapes and wine, laboratory methods for analysis of grapes and wines, sensory and organoleptic methods used for wine, the role of tannin and other phenolic compounds in wine, and some potential health aspects of wine. The talk will be combined with a "component and varietal analysis". During the component analysis, the audience will be given a reference wine sample with known levels of components such as acid, sugar, alcohol, etc. and then "unknown" samples in which one or more components have been increased by a known increment. During a varietal analysis a representative number of white and red wines will be compared.
Date: |
Tuesday October 28, 2014 – 5:30 p.m. (Heavy Appetizers), 7:00 p.m. (Presentation) |
Location: |
Location: Knobbe, Martens, Olson & Bear LLP 12790 El Camino Real San Diego, CA 92130 |
Price: |
$20 Registration in advance or at the door (includes buffet dinner and soft drinks/beer/wine)
|
Space is Limited — Register Early to Guarantee Your Attendance!
Click here for a printable flyer.
Our October 2014 meeting is generously sponsored by:
Knobbe, Martens, Olson & Bear LLP
For more information on sponsoring SCDMDG, please refer to our sponsorship guidelines.
Prior presentations:
Note: slides are displayed in a new window, left-click to advance, right-click to go back.
Speaker |
PDF |
Topic |
Date |
Lawrence J. Marnett, Ph.D., F.C.P |
|
Next Generation NSAIDs That Selectively Inhibit Endocannabinoid Metabolism by COX-2 |
May 6, 2014 |
Lawrence J. Lesko, Ph.D., F.C.P. |
|
Drug Interaction Studies: Differences and Similarities in How to Meet the Regulatory Expectations in FDA Guidance and EMA Guidelines |
May 14, 2013 |
Thomas Tozer, Ph.D. |
|
Pharmacokinetics of Protein Drugs |
October 23, 2012 |
Shujuan Chen |
|
Application of Animal Models for Human Glucuronidation |
October 23, 2012 |
Caroline Decker |
|
The Use of Modified Bacterial CYPs for Metabolite Generation |
October 23, 2012 |
Mary Dwyer, Ph.D. |
|
Cancer Therapeutics: A Novel Approach |
October 23, 2012 |
Justin Hoffman PharmD MS |
|
Population Pharmacokinetics (PK) of LopinavirDuring Pregnancy and Postpartum |
October 23, 2012 |
David A. Yee |
|
Observations on the Urine Metabolic Ratio of Oxymorphone to Oxycodone in Pain Patients |
October 23, 2012 |
Nabil Hanna, Ph.D. |
|
The Discovery and Development of Rituxan |
April 10, 2012 |
Dr. Richard Kim |
|
Drug Transporters: In Vitro and Knockout Model Systems, Pharmacogenomics, and Clinical Relevance |
April 19, 2011 |
Dr. Jerry Galluppi |
|
Biotherapeutic Drug Research and Development: A Growing Role for the DMPK Scientist |
October 5, 2010 |
Dr. Dennis Smith |
|
Does drug metabolism hold its future in its own hands? |
April 27, 2010 |
Dr. Paul F. Hollenberg |
|
Mechanism-Based Inactivation of Human Cytochromes P450 |
October 6, 2009 |
Dr. Jack H. Dean Dr. Thomas Baillie |
|
Challenges & Opportunities in Drug Development from a Drug Safety and Metabolism Perspective |
May 19, 2009 |
Eric Johnson, Ph.D. |
|
Characterization of Substrate/Inhibitor Binding to Drug-Metabolizing Cytochrome P450 Monooxygenases using X-ray Crystallography |
September 30, 2008 |
Dr. Kenneth E. Thummel, Ph.D. |
|
Regulation Of Intestinal CYP3A By VDR: Implications And Safety Of Oral Therapeutics |
May 7, 2008 |
Dr. Anthony Lu, Ph.D. |
|
Why Is The Liver Microsomal Cytochrome P450 Such A Versatile And Unique Enzyme? |
September 12, 2007 |
Dr. Scott Obach, Ph.D. |
|
Leveraging ADME Data In Metabolites In Safety Testing (MIST) |
April 18, 2007 |
Dr. Sidney Nelson, Ph.D. |
|
Drug Metabolism and Chemical Structural Alerts |
September 27, 2006 |
Richard B. Kim, MD |
|
Relevance and Utility of Transporters to Drug Discovery and Development |
September 21, 2005 |
Dr. Frederick P. Guengerich, Ph.D. |
|
Human Cytochrome P450 2A6 as a Case History: Flavors, Smoke, Blue Roses, New Drugs & Basics of a P450 |
April 27, 2005 |
Dr. Leslie Benet, Ph.D. |
|
Predicting Drug Disposition via Application of BCS: Transport/Absorption/Elimination Interplay and BDDCS |
September 29, 2004 |
Dr. Christopher A. Lipinski, Ph.D. |
|
ADME/Tox: How Low Can You Go And How Do You Recover? |
April 21, 2004 |
|
|
|